SSTR5 and metastatic neoplasm: This, together with results from the NEtD model and NEPC clinical samples, implicate SSTR5-AS1 and LINC00514 in NEPC and these lncRNAs serve as strong candidates as predictive biomarkers for metastatic disease post-RP following ADT.